OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 91 filers reported holding OVID THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $92,237 | -72.5% | 24,020 | -71.9% | 0.00% | – |
Q2 2021 | $335,000 | +161.7% | 85,566 | +167.0% | 0.00% | – |
Q1 2021 | $128,000 | +70.7% | 32,052 | -1.4% | 0.00% | – |
Q4 2020 | $75,000 | -50.7% | 32,492 | +23.0% | 0.00% | – |
Q3 2020 | $152,000 | -5.0% | 26,418 | +21.3% | 0.00% | – |
Q2 2020 | $160,000 | +66.7% | 21,785 | -6.0% | 0.00% | – |
Q4 2019 | $96,000 | +190.9% | 23,165 | +125.6% | 0.00% | – |
Q3 2019 | $33,000 | +450.0% | 10,269 | +208.3% | 0.00% | – |
Q2 2019 | $6,000 | -98.7% | 3,331 | -98.7% | 0.00% | – |
Q1 2019 | $454,000 | +263.2% | 257,262 | +394.4% | 0.00% | – |
Q4 2018 | $125,000 | -95.5% | 52,032 | -89.5% | 0.00% | -100.0% |
Q3 2018 | $2,795,000 | -40.9% | 493,427 | -18.6% | 0.00% | 0.0% |
Q2 2018 | $4,727,000 | +126.3% | 606,245 | +105.0% | 0.00% | 0.0% |
Q1 2018 | $2,089,000 | +0.3% | 295,722 | +40.1% | 0.00% | 0.0% |
Q4 2017 | $2,082,000 | +18.9% | 211,101 | +3.2% | 0.00% | 0.0% |
Q3 2017 | $1,751,000 | -18.8% | 204,494 | -0.6% | 0.00% | -50.0% |
Q2 2017 | $2,157,000 | – | 205,826 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AWH Capital, L.P. | 230,000 | $407,000 | 0.69% |
BVF INC/IL | 3,293,000 | $5,829,000 | 0.65% |
COWEN INC. | 1,101,414 | $1,950,000 | 0.21% |
ARMISTICE CAPITAL, LLC | 1,780,000 | $3,151,000 | 0.17% |
Granite Point Capital Management, L.P. | 417,857 | $740,000 | 0.07% |
Redmile Group, LLC | 737,550 | $1,305,000 | 0.04% |
Tekla Capital Management LLC | 496,977 | $880,000 | 0.04% |
Fairpointe Capital LLC | 101,000 | $179,000 | 0.01% |
Alyeska Investment Group, L.P. | 225,000 | $398,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 84,440 | $149,000 | 0.00% |